Abiopharma

Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Sight Sciences to Present at Two Upcoming Investor Conferences

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Viking Therapeutics to Participate at Upcoming Investor Conferences

ImmuCell Announces Onboarding of New CEO and Related Management Changes

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

OrthoPediatrics to Participate in Upcoming Conferences

Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements

Standard BioTools Reports Third Quarter 2025 Financial Results